BioVie Statistics

Total Valuation

BioVie has a market cap or net worth of $33.22 million. The enterprise value is $14.64 million.

Market Cap	33.22M
Enterprise Value	14.64M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

BioVie has 9.08 million shares outstanding. The number of shares has increased by 49.16% in one year.

Current Share Class	9.08M
Shares Outstanding	9.08M
Shares Change (YoY)	+49.16%
Shares Change (QoQ)	+4.67%
Owned by Insiders (%)	14.94%
Owned by Institutions (%)	16.36%
Float	5.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.55
P/TBV Ratio	2.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.26.

Current Ratio	2.95
Quick Ratio	2.93
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.85

Financial Efficiency

Return on equity (ROE) is -236.52% and return on invested capital (ROIC) is -84.27%.

Return on Equity (ROE)	-236.52%
Return on Assets (ROA)	-70.63%
Return on Capital (ROIC)	-84.27%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.38% in the last 52 weeks. The beta is 0.90, so BioVie's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	-91.38%
50-Day Moving Average	2.28
200-Day Moving Average	4.67
Relative Strength Index (RSI)	66.12
Average Volume (20 Days)	5,461,387

Short Selling Information

The latest short interest is 1.92 million, so 21.17% of the outstanding shares have been sold short.

Short Interest	1.92M
Short Previous Month	187,744
Short % of Shares Out	21.17%
Short % of Float	35.56%
Short Ratio (days to cover)	0.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.43M
Pretax Income	-36.29M
Net Income	-26.12M
EBITDA	-25.20M
EBIT	-25.43M
Earnings Per Share (EPS)	-$5.14

Full Income Statement

Balance Sheet

The company has $20.02 million in cash and $3.72 million in debt, giving a net cash position of $16.31 million or $1.80 per share.

Cash & Cash Equivalents	20.02M
Total Debt	3.72M
Net Cash	16.31M
Net Cash Per Share	$1.80
Equity (Book Value)	14.07M
Book Value Per Share	2.20
Working Capital	13.31M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.35M
Capital Expenditures	n/a
Free Cash Flow	-19.35M
FCF Per Share	-$2.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.16%
Shareholder Yield	-49.16%
Earnings Yield	-84.40%
FCF Yield	-62.51%

Analyst Forecast

The average price target for BioVie is $40.00, which is 992.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.00
Price Target Difference	992.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 6, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 6, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2